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1. INTRODUCTION 
Consumption of commercial supplements has 
tremendously increased in recent times in response to greater 
demand for the healthful and convenient purposes1. There are 
a wide range of commercial supplements available today in 
market to meet the additional nutritional needs which cannot 
be met through diet alone. Allied to this, there are specialised 
formulations for various disease states referred to as “top 
ups” to meet the needs of the population who are at risk of 
developing nutritional related complications2. Nowadays these 
formulations are available in a variety of forms like energy 
concentrates, liquid concentrates, drink powders, etc., which 
are convenient to use as oral health supplements and even 
preferred in tube feedings because of its association with 
minimal infections and lesser complications. 
Iron deficiency anemia (IDA), recognised as a public 
health problem, is not only prevalent in many countries 
among various groups and most common in vulnerable groups 
(children, pregnant women, elderly people, etc), it is also 
common among non-pregnant women, degenerative diseased 
subjects, infants, men, geriatric populations3. Iron is the most 
important micronutrient which functions in many metabolic 
processes by playing an integral role in biological systems by 
forming an intrinsic component of myoglobin, hemoglobin 
and cytochromes4. The effects of this mineral deficiency can 
be extensive, affecting health, fitness, cognitive development 
thereby reducing national productivity and socioeconomic 
development in many countries5. Efforts to address anemia 
have not been launched with the same level of intensity as 
those for the control of other micronutrients (Vitamin A and 
Iodine). Despite a sequence of national surveys, incorporation 
of national nutritional plans, external assistance by UNICEF, 
plan of action for implementation to combat iron deficiency 
anemia, it remains the most widely prevalent nutritional 
problem in India6. Although many factors are responsible 
for the onset of iron deficiency, the most likely cause of this 
nutritional problem in developing countries is insufficient 
intake through diet or poor bio-availability of dietary iron7. 
In-vitro bio-accessibility/bio-availability methods are less 
expensive, faster, and offer better control of experiment 
than in vivo methods. They give reliable knowledge on 
possible interactions between nutrients, food processing and 
preparation methods, nature of food matrix, micronutrient 
absorbability (bio-availability) or micronutrient potentiality 
(bio-accessibility)8.
Nutrition/food labelling is the important tool for 
consumers that provide information on the nutritional 
composition data which typically includes values for 
serving size, energy value, the amount of fats (unsaturated, 
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polyunsaturated and saturated fats), carbohydrates, dietary 
fiber (fibers), sugar, proteins, vitamins, minerals and other 
essential or physiologically useful substances which are 
considered to be nutrients in terms of nutritional labelling 
for foodstuffs9. However, information on bio-accessibility of 
nutrients from foods as well as commercial supplements is 
limited. The labelling of foodstuffs is playing an ever more 
important role in the purchasing decisions of consumers. The 
background for this is often the increasing level of awareness 
of health-relevant figures or ingredients, and the desire to 
be able to choose foodstuffs in relation to their individual 
requirements. The manufacturer and the distributor are 
responsible for the correctness of the nutritional value 
information. The information must be truthful and must not 
be intended to deceive the consumers10. Therefore, inclusion 
of bio-accessibility data would be useful in computing 
the recommended daily allowances and combating the 
micronutrient deficiency diseases by evolving a better diet 
strategy and thus improving the treatment efficacy.
The lack of studies on the bio-accessibility of nutrients in 
the commercial formulations which are extensively used both 
by healthy and diseased populations has driven the present study 
with an objective to analyze the nutritional composition and 
iron bio-accessibility in selected disease specific commercial 
formulations.
2. MATERIALS AND METHODS
2.1 Samples 
 Six commercially available formulations intended for use 
in different conditions like malnutrition, hyper metabolism, 
diabetes and pulmonary complications were selected and 
procured from the local pharmaceutical stores of Mysore, 
Karnataka, India. These supplements were coded as (CS-1, 
CS-2, CS-3, CS-4, CS-5 and CS-6) for the convenience 
of analysis. The samples were transferred into an air tight 
container and stored in ambient conditions until further usage. 
CS-1, CS-2, CS-3 are high protein, calorie dense supplements. 
CS-4, CS-5 are low glycemic index products and CS-6 is high 
fat, calorie dense supplement. The enzymes and solvents used 
for the analysis were from Sigma, Himedia, SD fine chemicals 
Ltd., Other chemicals were of analytical grade. Double distilled 
water was employed in iron bio-accessibility assay.
2.2 Methodology
 The formulations were subjected for proximate analysis, 
functional properties (bulk density, oil absorption capacity, 
and foaming capacity) by standard AOAC methods11 and other 
related properties like viscosity and flow rates which are a 
prerequisite for tube feeding application. Iron bio-accessibility 
was determined by In-vitro dialisability assays. 
2.3 Proximate Analysis
Moisture analysis was carried out by using automated 
moisture analyser Mettler Toledo MJ33. Fat was estimated 
using Soxhlet apparatus. Crude protein (Nx6.25) content was 
determined by micro Kjedhal method (AOAC methods)12. Ash 
content was analysed by igniting the sample in a muffle furnace 
at the temperature of 600 °C for 8 h. 
2.4 Total Iron and Calcium Content 
All the samples were ashed in muffle furnace at 600 °C 
for 8 h and the ash was dissolved in concentrated HCl (Sp.
Gr.1.18) to obtain the mineral solution. Total iron content 
was determined by ferrozine method as described by 
Ward13, et al. The mineral solution obtained was further treated 
with ascorbic acid (0.02 per cent in 0.2 N HCl) to reduce iron 
to the ferrous form. Known aliquots were treated with ascorbic 
acid, ammonium acetate (30 per cent) followed by ferrozine 
reagent (1 Mm in water). The coloured complex developed 
were read at 562 nm using spectrophotometer after incubating 
in dark for 15minutes. Calibration of measurements was 
performed using iron standard. 
The total iron content was determined by plotting the 
standard curve and measuring the iron content. Calcium was 
estimated by titrating the mineral solution against potassium 
permanganate (0.01N).
2.5 Determination of Bio-accessibility of Iron 
Iron bio-accessibility of samples was measured by an 
In-vitro method involving gastric simulations as described 
by Luten14, et al. Finely powdered samples were subjected to 
simulate human digestive system via a three step digestion that 
includes gastric stage, titrable acidity and intestinal digestion 
stage. Known amount of samples were acidified (pH 2) with 6 
M Hydrochloric acid and incubated with 3ml freshly prepared 
pepsin solution (1 l of 0.1 M HCl containing 16 g pepsin) for 
2 h at 37 °C. The gastric digested mixture was stored in ice 
packs for 90 min. Titrable acidity was measured with a known 
gastric digested aliquot at 20 °C by adjusting the pH to 7.5 with 
0.5 M sodium hydroxide in the presence of pancreatin–bile 
extract mixture (1 L of 0.1 M sodium bicarbonate containing 
4 g pancreatin + 25 g bile extract). The intestinal stage was 
proceeded further with segments of dialyzing tube ( Molecular 
mass cut off 15 kDa) containing 25 ml of sodium bicarbonate 
solution, equivalent in moles to sodium hydroxide which is 
needed to neutralise the gastric digested mixture. The contents 
were taken in acid washed flasks and incubated with 5 ml 
pancreatin- bile extract for 2 h at 37 °C with periodic shaking 
at 30 min interval. At the end of intestinal stage, the contents of 
the dialysing tubes were analysed for iron content.
 The dialysable portion of iron present in the sample 
(expressed as per cent) represented the bio-accessible mineral.
Bio-accessibility of iron in (per cent) was calculated as 
the ratio of the (A) elemental content of bio-accessible fraction 
(mg/100g) to the (B) total iron content (mg/100g) of the sample. 
The formula is as follows:
Bio-accessibility (per cent) = A/BX100
2.6 Functional Properties (Bulk Density, Oil 
Absorption Capacity and Foaming Capacity)
(i) Bulk density: Samples (3 g) in triplicates were taken in 
a 10 ml dry measuring cylinder. The cylinder was gently 
tapped on a rubber mat continuously until a constant 
volume was obtained. The bulk density was recorded as 
g/100 ml Wang and Kinsella15.
(ii) Fat absorption: Samples (1 g) in triplicates were taken in 
centrifuge tubes to which 5 ml of refined oil was added 
208
SIDDIqI, et al.: DEF. LIFE SCI. J., VOL. 2, NO. 2, ApRIL 2017, DOI : 10.14429/dlsj.2.11360
and centrifuged at 3000 rpm for 20 min. The tubes were 
decanted and the supernatant was measured in ml. The 
volume of oil absorbed by the sample was expressed in 
ml/100g of sample. (Sosulski16 , et al.)
(iii) Foaming capacity: 1 g of sample in triplicates was 
homogenised with 100ml of water for 5min. The mixture 
was then transferred to a 250 ml measuring cylinder and 
the foam was recorded in ml. The foaming capacity of the 
samples was expressed as percent foam using the formula 
given below; per cent foaming capacity = volume after 
homogenisation–volume before homogenisation * 100 / 
Volume before homogenisation
2.7 Other Aspects (Flow Rate and Viscosity)
(i) Flow rate: The flow rate of the samples was determined 
using Ryle’s tubes of different sizes i.e., 12, 14 and 16 
French units. Flow rate of each sample was recorded in 
minutes corresponding to different sizes of the tube.
(ii) Viscosity: known weight of the sample in triplicates 
was mixed with 100 ml of water and the viscosity was 
determined using Brookfield DV-II+pro Viscometer. 
Viscosity was expressed as centi poise (cp).
3.  STATISTICAL ANALySIS
All the experiments were carried out in triplicates, (n=3). 
The values for any experiment were mean of the triplicate 
values and are expressed in mean of the triplicate experiments 
with SD. For the evaluation of significant difference, the data 
were subjected to a one way ANOVA, followed by Tukey’s 
post-hoc multiple comparison test for the formulations. 
Confidence interval (95 per cent) was used as appropriate to 
evaluate the quality of the descriptive analysis using SpSS 
version 16 software. 
4.  RESULTS 
4.1  Proximate Analysis of Commercial Samples
The nutritional composition of the samples is reported in 
Table 1. Results showed that there was no difference among 
the samples with respect to moisture content except for CS-3 
sample which was high (p<0.05). The moisture content ranged 
between 2.51 per cent to 5.78 per cent which was very much 
consistent among the formulations. The samples tremendously 
varied in fat content ranging with least value of 0.8 per cent 
observed in CS-3 formulation to the highest in CS-1 with 
22.6 per cent. Meanwhile, the average protein content between 
the samples was 27.15 per cent and it is evident from the table 
that CS-5 had the highest followed by CS-2. Least protein was 
observed in CS-1 formulation. The total ash content represents 
the total mineral content of the samples; among the samples 
analysed highest soluble ash was found to be in CS-6 (3.39 per 
cent) and least in CS-3 with 0.71 per cent at 5 per cent level of 
significance. 
4.2 Total Iron and Calcium Content 
The total iron and calcium content of the selected samples 
is reported in Table 2. The iron content within the samples 
varied significantly (p<0.05) and the contents of iron and 
calcium analysed in this study corresponded with the reported 
values on the nutritional labelling of the formulations. Iron 
content ranged from 8.66 mg/100 g least in CS-6 to 21.72 
mg/100 g highest in CS-3. However, majority of the samples 
had uniform trend values for iron content. The percentage of 
calcium content significantly differed (p<0.05) among the 
samples. Highest calcium was reported in CS-6 and lowest 
in CS-1. 
4.3 Iron Bio-accessibility of the Samples 
The samples were analysed for the bio-accessibility of iron 
using In-vitro dializability assay and the values obtained are 
reported in Fig. 1. It is observed that the iron bio-accessibility 
of the samples is significantly (p<0.05) lower than the total 
iron content presented in table 2. Bio-accessibility value of iron 
content of the samples ranged between 0.05 mg/100 g – 0.32 
mg/100 g which is tenfold lower than the total iron content. 
The per cent bio-accessibility value was also determined 
taking the ratio of the elemental content of bio-accessible 
fraction (mg/100 g) to the total iron content (mg/100 g) of the 
formulations and was observed to be highest in CS-1 with 2.52 
per cent and lowest in CS-3 (0.23 per cent).
4.4  Functional Properties 
Functional properties of commercial sample are shown in 
Table 3. CS-5 had lowest and CS-6 had the highest bulk density. 
Among the samples, CS-6 had the highest fat absorption, 
followed by CS-2 and CS-4 had the least fat absorption value 
of 40ml/100g. Foaming capacity depends on solubility and 
surface activity of the protein. Foaming capacity of the samples 
ranged between 2-41 per cent . 
Table 1.  Proximate analysis of commercial samples (Dry weight basis)
Sample Moisture (per cent) Fat (g/100 g) Protein (per cent) Total ash  (g/100 g) Soluble ash (g/100 g) Insoluble ash  (g/100 g)
CS-1 2.55 ± 0.05a 22.67 ± 1.90a 19.75 ± 1.53a 2.56 ± 0.54b 2.45 ± 0.51d 0.10 ± 0.07a
CS-2 4.58 ± 0.43b 12.05 ± 0.14b 33.26 ± 3.93c 1.66 ± 0.05b 1.61 ± 0.01b 0.05 ± 0.04c
CS-3 5.78 ± 0.16c 0.8 ± 0.12c 29.98 ± 1.49b 0.67 ± 0.01c 0.71 ± 0.00a 0.037 ± 0.06b
CS-4 4.19 ± 0.06b 20.145 ± 1.29a 21.10 ± 2.38a 3.30 ± 0.02a 1.58 ± 0.19b 1.72 ± 0.22d
CS-5 4.67 ± 0.45b 2.09 ± 0.08c 38.44 ± 2.91c 3.06 ± 0.24a 3.08 ± 0.14c 0.039 ± 0.00b
CS-6 2.51 ± 0.08a 17.5 ± 0.67a 20.38 ± 1.31a 3.36 ± 0.04a 3.39 ± 0.18c 0.16 ± 0.04a
Mean values with the same superscript(s) in a column are not significantly different at (p<0.05)
Representations: CS-1(Commercial sample-1), CS-2(Commercial sample-2), CS-3(Commercial sample-3), CS-4 (Commercial sample-4), CS-5(Commercial 
sample-5), CS-6 (Commercial sample-6) 
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Figure 1.  Iron bio-accessibility in the formulations.            
Table 3.  Functional properties of commercial sample
4.5 Other Aspects 
Other aspects include flow rate and viscosity. Flow rate 
and viscosity are inter-dependent. Flow rate of the sample 
decreases with the increase in viscosity of the sample. The flow 
rate of different samples is reported in Table 4. As it is evident 
from the table, there was reduction in time in minutes against 
the different sizes of the Ryle’s tube which was used to measure 
the flow rate of the samples. The samples were determined for 
their viscosity and the values are reported in Table 5. From 
the results, it is observed that CS-5 had the highest viscosity 
of 14.5 cp (centi poise) and CS-2 had the lowest viscosity of 
6.6 cp.
Table 2.  Total iron and calcium content of samples
Sample Total iron (mg/100 g) Calcium (mg/100 g)
CS-1 12.14 ± 1.34d 150 ± 0.02f
CS-2 20.62 ± 4.5a 1200± 0.04a
CS-3 21.72 ± 1.44b 650 ± 0.12d
CS-4 20.00 ± 0.2a 300 ± 1.14c
CS-5 19.05 ± 4.05b 480 ± 0.70e
CS-6 8.66 ± 0.50c 1000 ± 0.01b
Mean values with the same superscript(s) in a column are not significantly 
different at (p<0.05)
Sample Bulk density 
(g/100 ml)
Oil absorption 
capacity (ml/100g)
Foaming 
capacity (%)
CS-1 57.69 ± 00a 80 ± 00b 16
CS-2 47.37 ± 0.87d 86.67 ± 11.55b 2
CS-3 54.89 ± 1.14a 60 ± 00a 10
CS-4 52.95 ± 1.06a 40 ± 00c 41
CS-5 41.85 ± 0.34b 66.67 ± 11.54d 23
CS-6 63.40 ± 1.56c 106.67 ± 11.54e 2.33
Mean values with the same superscript(s) in a column are significantly 
different at (p<0.05)
Sample RT size Time (min)
CS-1 12 19.5 ± 4.94
14 12 ± 0
16 9.5 ± 0.70
CS-2 12 11.5 ± 0.70
14 7.5 ± 0.70
16 7 ± 0
CS-3 12 11.5 ± 0.70
14 8.5 ± 0.70
16 7.5 ± 0.70
CS-4 12 20 ± 0
14 15 ± 0
16 10 ± 0
CS-5 12 17.5 ± 0.70
14 12.5 ± 0.70
16 10 ± 0
CS-6 12 11 ± 0
14 10 ± 1.41
16 8 ± 0
Table 4.   Flow rates of samples
Sample Viscosity (cP)
CS-1 9.45 ±0.21
CS-2 6.6 ±0.84
CS-3 6.15 ±0.21
CS-4 11.4 ±0.42
CS-5 14.5 ±0.21
CS-6 8.4 ±0.42
Table 5.   Viscosities of samples
5. DISCUSSION
The possible reason for the variation in CS-3 is the 
protein content which affects moisture. The differences in fat 
content could be possibly attributed to the microencapsulation 
technology employed during the processing of commercial 
formulations which have inhibited the fat to get extracted 
completely. The variations in the mineral contents might 
be attributed to the involvement of other micro-nutrient 
interactions. In this context, the interactions can be from quality 
of protein, calcium, fiber, etc17. Iron is present in both divalent 
and trivalent forms among the various other minerals; therefore 
absorbability is affected by the form of availability18.
In addition, differences in the bio-accessibilities of iron 
within the samples were also observed. Such differences in the 
mineral bio-accessibility values may be attributed to various 
inherent factors associated with the formulations19 and can also 
be attributed to the amount and or quality of proteins which 
may influence trace element bio-accessibility20. High protein 
supplements, especially those based on animal protein, are 
reported to enhance the bio-availability of trace minerals, 
probably by formation of the soluble amino acid complexes, 
which facilitates absorption of the former21. 
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Bulk density is the measure of heaviness of the powders. 
It depends on the particle density, which in turn is determined 
by solid density and internal particle porosity22. Higher bulk 
density is desirable as it offers greater packaging convenience. 
Oil absorption capacity depends on the amount of non-polar 
amino acids present in proteins. The presence of more non-
polar side chains facilitates binding of fats, thereby resulting 
in higher fat absorption. The differences in foaming capacity 
among the samples could be due to their differences in protein 
concentration23. Commercial supplements are used as oral 
supplements as well as employed in enteral feeding. Therefore, 
measurement of flow rate is an important criterion which has 
to be measured along with viscosity. Viscosity of a fluid is 
the measure of its resistance to gradual deformation tensile 
stress. For liquids, it corresponds to the informal concept of 
thickness.
6. CONCLUSION 
This research paper is the first study reporting the nutritional 
and bio-accessibility assays of the selected disease specific 
formulations locally available in the Indian market. There are 
a wide variety of supplements available commercially today 
in the market to meet nutritional demands of individual in the 
clinical settings. These supplements are preferred frequently 
because of its convenient application as oral supplements 
and even in tube feeding as they are associated with lesser 
complications. Various interventions have been developed 
and designed to prevent and correct iron deficiency anemia, 
which includes improved dietary methods, food fortification, 
supplementation, and other complementary approaches -public 
health measures (deworming). Although many factors are 
responsible for the onset of iron deficiency anemia, the most 
important one is the poor bio-availability of dietary iron. 
Labelling of foodstuffs plays a vital role in the purchasing 
decisions of consumers. Therefore, the study emphasizes on 
the promotion of nutritional labelling of bio-accessible data on 
vital minerals (iron) particularly as an effective tool to combat 
iron deficiency anemia. Use of supplements with higher bio-
availability may result in usage of lower doses of iron with 
fewer side effects, thus improving treatment efficacy. Hence, 
there is a need to create awareness among pharmaceutical and 
manufacturing companies to highlight the inclusion of bio-
accessibility values of micronutrients of importance rather 
than the usual nutritional composition data, as a vital attribute 
in food labelling to combat widespread deficiency among the 
population. 
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